Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell

Regina Kuliawat, Laura Klein, Zhenwei Gong, Marianna Nicoletta-Gentile, Anjana Nemkal, Lingguang Cui, Claire Bastie, Kai Su, Derek M. Huffman, Manju Surana, Nir Barzilai, Norman Fleischer, Radhika Muzumdar

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Humanin (HN) is a 24-aa polypeptide that offers protection from Alzheimer's disease and myocardial infarction, increases insulin sensitivity, improves survival of cells, and delays onset of diabetes. Here we examined the acute effects of HN on insulin secretion and potential mechanisms through which they are mediated. Effects of a potent HN analog, HNGF6A, on glucose-stimulated insulin secretion (GSIS) were assessed in vivo and in isolated pancreatic islets and cultured murine cell line (TC3) in vitro. Sprague- Dawley rats (3 mo old) that received HNGF6A required a significantly higher glucose infusion rate and demonstrated higher insulin levels during hyperglycemic clamps compared to saline controls. In vitro, compared to scrambled peptide controls, HNGF6A increased GSIS in isolated islets from both normal and diabetic mice as well as in TC3 cells. Effects of HNGF6A on GSIS were dose dependent, K-ATP channel independent, and associated with enhanced glucose metabolism. These findings demonstrate that HNGF6A increases GSIS in whole animals, from isolated islets and from cells in culture, which suggests a direct effect on the cell. The glucose-dependent effects on insulin secretion along with the established effects on insulin action suggest potential for HN and its analogs in the treatment of diabetes.-Kuliawat, R., Klein, L., Gong, Z., Nicoletta-Gentile, M., Nemkal, A. Cui, L., Bastie, C., Su, K., Huffman, D., Surana, M., Barzilai, N., Fleischer, N., Muzumdar, R. Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell.

Original languageEnglish (US)
Pages (from-to)4890-4898
Number of pages9
JournalFASEB Journal
Volume27
Issue number12
DOIs
StatePublished - Dec 2013

Fingerprint

Metabolism
Insulin
Glucose
Islets of Langerhans
Medical problems
Cells
humanin
Peptides
Clamping devices
Action Potentials
Sprague Dawley Rats
Insulin Resistance
Cultured Cells
Cell Survival
Alzheimer Disease
Rats
Cell Culture Techniques
Adenosine Triphosphate
Myocardial Infarction
Animals

Keywords

  • Diabetes
  • Hyperglycemic clamps
  • Pancreatic islets

ASJC Scopus subject areas

  • Biochemistry
  • Biotechnology
  • Genetics
  • Molecular Biology

Cite this

Kuliawat, R., Klein, L., Gong, Z., Nicoletta-Gentile, M., Nemkal, A., Cui, L., ... Muzumdar, R. (2013). Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell. FASEB Journal, 27(12), 4890-4898. https://doi.org/10.1096/fj.13-231092

Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell. / Kuliawat, Regina; Klein, Laura; Gong, Zhenwei; Nicoletta-Gentile, Marianna; Nemkal, Anjana; Cui, Lingguang; Bastie, Claire; Su, Kai; Huffman, Derek M.; Surana, Manju; Barzilai, Nir; Fleischer, Norman; Muzumdar, Radhika.

In: FASEB Journal, Vol. 27, No. 12, 12.2013, p. 4890-4898.

Research output: Contribution to journalArticle

Kuliawat, R, Klein, L, Gong, Z, Nicoletta-Gentile, M, Nemkal, A, Cui, L, Bastie, C, Su, K, Huffman, DM, Surana, M, Barzilai, N, Fleischer, N & Muzumdar, R 2013, 'Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell', FASEB Journal, vol. 27, no. 12, pp. 4890-4898. https://doi.org/10.1096/fj.13-231092
Kuliawat, Regina ; Klein, Laura ; Gong, Zhenwei ; Nicoletta-Gentile, Marianna ; Nemkal, Anjana ; Cui, Lingguang ; Bastie, Claire ; Su, Kai ; Huffman, Derek M. ; Surana, Manju ; Barzilai, Nir ; Fleischer, Norman ; Muzumdar, Radhika. / Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell. In: FASEB Journal. 2013 ; Vol. 27, No. 12. pp. 4890-4898.
@article{2cdec7c2223c4627b269b104b3d1b2da,
title = "Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell",
abstract = "Humanin (HN) is a 24-aa polypeptide that offers protection from Alzheimer's disease and myocardial infarction, increases insulin sensitivity, improves survival of cells, and delays onset of diabetes. Here we examined the acute effects of HN on insulin secretion and potential mechanisms through which they are mediated. Effects of a potent HN analog, HNGF6A, on glucose-stimulated insulin secretion (GSIS) were assessed in vivo and in isolated pancreatic islets and cultured murine cell line (TC3) in vitro. Sprague- Dawley rats (3 mo old) that received HNGF6A required a significantly higher glucose infusion rate and demonstrated higher insulin levels during hyperglycemic clamps compared to saline controls. In vitro, compared to scrambled peptide controls, HNGF6A increased GSIS in isolated islets from both normal and diabetic mice as well as in TC3 cells. Effects of HNGF6A on GSIS were dose dependent, K-ATP channel independent, and associated with enhanced glucose metabolism. These findings demonstrate that HNGF6A increases GSIS in whole animals, from isolated islets and from cells in culture, which suggests a direct effect on the cell. The glucose-dependent effects on insulin secretion along with the established effects on insulin action suggest potential for HN and its analogs in the treatment of diabetes.-Kuliawat, R., Klein, L., Gong, Z., Nicoletta-Gentile, M., Nemkal, A. Cui, L., Bastie, C., Su, K., Huffman, D., Surana, M., Barzilai, N., Fleischer, N., Muzumdar, R. Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell.",
keywords = "Diabetes, Hyperglycemic clamps, Pancreatic islets",
author = "Regina Kuliawat and Laura Klein and Zhenwei Gong and Marianna Nicoletta-Gentile and Anjana Nemkal and Lingguang Cui and Claire Bastie and Kai Su and Huffman, {Derek M.} and Manju Surana and Nir Barzilai and Norman Fleischer and Radhika Muzumdar",
year = "2013",
month = "12",
doi = "10.1096/fj.13-231092",
language = "English (US)",
volume = "27",
pages = "4890--4898",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "12",

}

TY - JOUR

T1 - Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell

AU - Kuliawat, Regina

AU - Klein, Laura

AU - Gong, Zhenwei

AU - Nicoletta-Gentile, Marianna

AU - Nemkal, Anjana

AU - Cui, Lingguang

AU - Bastie, Claire

AU - Su, Kai

AU - Huffman, Derek M.

AU - Surana, Manju

AU - Barzilai, Nir

AU - Fleischer, Norman

AU - Muzumdar, Radhika

PY - 2013/12

Y1 - 2013/12

N2 - Humanin (HN) is a 24-aa polypeptide that offers protection from Alzheimer's disease and myocardial infarction, increases insulin sensitivity, improves survival of cells, and delays onset of diabetes. Here we examined the acute effects of HN on insulin secretion and potential mechanisms through which they are mediated. Effects of a potent HN analog, HNGF6A, on glucose-stimulated insulin secretion (GSIS) were assessed in vivo and in isolated pancreatic islets and cultured murine cell line (TC3) in vitro. Sprague- Dawley rats (3 mo old) that received HNGF6A required a significantly higher glucose infusion rate and demonstrated higher insulin levels during hyperglycemic clamps compared to saline controls. In vitro, compared to scrambled peptide controls, HNGF6A increased GSIS in isolated islets from both normal and diabetic mice as well as in TC3 cells. Effects of HNGF6A on GSIS were dose dependent, K-ATP channel independent, and associated with enhanced glucose metabolism. These findings demonstrate that HNGF6A increases GSIS in whole animals, from isolated islets and from cells in culture, which suggests a direct effect on the cell. The glucose-dependent effects on insulin secretion along with the established effects on insulin action suggest potential for HN and its analogs in the treatment of diabetes.-Kuliawat, R., Klein, L., Gong, Z., Nicoletta-Gentile, M., Nemkal, A. Cui, L., Bastie, C., Su, K., Huffman, D., Surana, M., Barzilai, N., Fleischer, N., Muzumdar, R. Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell.

AB - Humanin (HN) is a 24-aa polypeptide that offers protection from Alzheimer's disease and myocardial infarction, increases insulin sensitivity, improves survival of cells, and delays onset of diabetes. Here we examined the acute effects of HN on insulin secretion and potential mechanisms through which they are mediated. Effects of a potent HN analog, HNGF6A, on glucose-stimulated insulin secretion (GSIS) were assessed in vivo and in isolated pancreatic islets and cultured murine cell line (TC3) in vitro. Sprague- Dawley rats (3 mo old) that received HNGF6A required a significantly higher glucose infusion rate and demonstrated higher insulin levels during hyperglycemic clamps compared to saline controls. In vitro, compared to scrambled peptide controls, HNGF6A increased GSIS in isolated islets from both normal and diabetic mice as well as in TC3 cells. Effects of HNGF6A on GSIS were dose dependent, K-ATP channel independent, and associated with enhanced glucose metabolism. These findings demonstrate that HNGF6A increases GSIS in whole animals, from isolated islets and from cells in culture, which suggests a direct effect on the cell. The glucose-dependent effects on insulin secretion along with the established effects on insulin action suggest potential for HN and its analogs in the treatment of diabetes.-Kuliawat, R., Klein, L., Gong, Z., Nicoletta-Gentile, M., Nemkal, A. Cui, L., Bastie, C., Su, K., Huffman, D., Surana, M., Barzilai, N., Fleischer, N., Muzumdar, R. Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the cell.

KW - Diabetes

KW - Hyperglycemic clamps

KW - Pancreatic islets

UR - http://www.scopus.com/inward/record.url?scp=84890544217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890544217&partnerID=8YFLogxK

U2 - 10.1096/fj.13-231092

DO - 10.1096/fj.13-231092

M3 - Article

C2 - 23995290

AN - SCOPUS:84890544217

VL - 27

SP - 4890

EP - 4898

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 12

ER -